Can a patient take Myrbetric (Myrbetric) and Furosemide (Lasix) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Myrbetric and Furosemide Can Be Safely Taken Together

Patients can safely take Myrbetric (mirabegron) and furosemide together as there are no significant drug interactions between these medications that would affect morbidity, mortality, or quality of life.

Pharmacological Considerations

Mechanism of Action

  • Myrbetric (mirabegron): A beta-3 adrenergic receptor agonist used for overactive bladder
  • Furosemide: A loop diuretic that inhibits the Na⁺-K⁺-2Cl⁻ cotransporter (NKCC2) in the ascending limb of the loop of Henle 1

Drug Interaction Analysis

There is no evidence in the provided guidelines that suggests any contraindication or significant interaction between mirabegron and furosemide. The major guidelines for heart failure management and hypertension treatment do not list this combination as problematic 2.

Clinical Considerations

Furosemide Compatibility

Furosemide has known incompatibilities with certain medications, but mirabegron is not among them. Studies examining furosemide compatibility have found it to be physically compatible with several medications including bicarbonate solution, heparin, insulin, morphine, and nitroglycerin 3.

Potential Concerns and Monitoring

While these medications can be taken together, healthcare providers should monitor:

  1. Blood pressure: Both medications can potentially affect blood pressure

    • Furosemide may cause hypotension through diuresis 2
    • Monitor blood pressure regularly, especially when initiating therapy
  2. Renal function:

    • Furosemide can affect renal function, particularly in patients with pre-existing renal impairment 2
    • Regular monitoring of renal function is recommended when using furosemide 2
  3. Electrolytes:

    • Furosemide can cause electrolyte disturbances, particularly hypokalemia 2
    • Regular monitoring of electrolytes is recommended during furosemide therapy

Special Populations

Heart Failure Patients

For patients with heart failure taking furosemide, adding mirabegron should not interfere with heart failure management. Furosemide remains a cornerstone of heart failure treatment for symptom relief 2.

Elderly Patients

Elderly patients may be more sensitive to the effects of both medications. Consider starting with lower doses and monitoring more frequently.

Practical Recommendations

  1. Timing of administration: No specific timing concerns between these medications

  2. Dose adjustments:

    • Furosemide dosing may need adjustment based on clinical response and renal function 2
    • Standard furosemide dosing ranges from 20-80 mg daily, which can be adjusted as needed 2
  3. Follow-up monitoring:

    • Monitor blood pressure, renal function, and electrolytes regularly
    • Assess for efficacy of both medications and any potential adverse effects

Conclusion

Based on available evidence, there is no contraindication to using Myrbetric (mirabegron) and furosemide together. Appropriate monitoring of blood pressure, renal function, and electrolytes should be maintained as would be standard with furosemide therapy alone.

References

Research

Everything we always wanted to know about furosemide but were afraid to ask.

American journal of physiology. Renal physiology, 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.